Enter the MedStartr Launchathon — Aug 1–Oct 6 in NYC
< Back to companies
NVIDIA

NVIDIA

Powering Healthcare AI Innovation

Santa Clara, California, USA

OtherPublic

NVIDIA is a publicly traded technology company on NASDAQ (NVDA) that is a major investor in AI and deep learning. It has made significant investments in companies like OpenAI, Anthropic, Mistral AI, and Cohere, and partners with GE HealthCare for medical technology development.

Hero image for NVIDIA
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Get Involved in NVIDIA
Claim This Profile →

How We Help

Problem Statement

Healthcare stakeholders often lack the foundational computing power and advanced AI tools necessary to drive innovation efficiently. NVIDIA solves this by providing essential hardware and software infrastructure, reducing barriers to entry for developing new diagnostics, therapies, and operational efficiencies.

Core Technology

Graphics Processing Units (GPUs), Artificial Intelligence (AI) and Deep Learning, Accelerated Computing, Specialized Platforms (NVIDIA Clara, BioNeMo, Holoscan, MONAI, Isaac for Healthcare), Digital Twin Technology

Key Differentiators

GPU Leadership, Full-Stack AI Platform, Ecosystem Enablement, Pioneering AI in Physical World (Physical AI), Accelerated Drug Discovery and Genomics, Strategic Partnerships (with nearly 200 organizations and 3,500 startups)

Clinical Focus

Supporting innovation across oncology, cardiovascular, central nervous system, immunology, infectious diseases, respiratory, rare diseases, and neurodegenerative conditions.

Target Customers

Other companies and institutions, hospitals, device makers, drug manufacturers, researchers

Product Stage

Mature

Company Info

Business Model
B2B
Founded
1993
Website
www.nvidia.com/healthcare

Categories

Other

Disease Areas

Technologies

AIGPUsDeep LearningAccelerated ComputingNVIDIA ClaraBioNeMoHoloscanMONAIIsaac for HealthcareDigital Twin TechnologyPhysical AIGenomics

MedStartr Index Score

?
27

What do you think of NVIDIA?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in NVIDIA